FOCAL SEIZURE
Clinical trials for FOCAL SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Epilepsy drug vormatrigine moves to Long-Term safety check in 700 patients
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of the drug vormatrigine in adults with epilepsy who have already taken it in earlier studies. About 700 people will take the drug and be monitored for side effects like changes in temperature, heart rate, and blood pressure. The goal is to s…
Matched conditions: FOCAL SEIZURE
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated May 17, 2026 02:34 UTC
-
New epilepsy pill takes first step: safety check in healthy people
Knowledge-focused OngoingThis early-stage study tests whether a new oral drug called iQ-007 is safe and tolerable in 72 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to gather …
Matched conditions: FOCAL SEIZURE
Phase: PHASE1 • Sponsor: iQure Australia Pty Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC